Wilson Sonsini Goodrich & Rosati advised Aramis Biosciences on the deal. Aramis Biosciences, a clinical-stage immuno-ophthalmology biopharmaceutical company, announced its launch and the completion of a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Clearway on the deal. Clearway Energy Group LLC announced that the entire output from its Arica Solar + Energy Storage...
You must be a Standard 1 Year member to access this content.
J.P. Morgan acted as exclusive financial advisor to Encora in connection with the transaction and Wilson, Sonsini, Goodrich & Rosati LLP served as legal advisor. Credit...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian and Cuatrecasas advised Addi on the deal. Wilson Sonsini Goodrich & Rosati and Philippi Prietocarrizosa Ferrero DU & Uría...
You must be a Standard 1 Year member to access this content.
Freshfields advised Morgan Stanley on the deal while Wilson Sonsini Goodrich & Rosati represented Samsara. Morgan Stanley acted as representative of the underwriters on the initial...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Regor Therapeutics on the deal. Eli Lilly and Company and Regor Therapeutics Group entered into a multi-year research collaboration and...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Innovaccer on the deal. Innovaccer Inc. announced a $150 million Series E round at a $3.2 billion valuation, driven by...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Chroma Medicine on the deal. Chroma Medicine, a new genomic medicine company pioneering epigenetic editing, launched with $125 million in...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised HashiCorp on the deal. Latham & Watkins represented the underwriters. HashiCorp®, a leader in multi-cloud infrastructure automation software, announced the pricing...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised AppLovin on the deal. AppLovin Corporation, a leading marketing software company, announced the pricing of its underwritten public offering of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Recursion on the deal. Recursion, a clinical-stage biotechnology company decoding biology to radically improve lives by industrializing drug discovery, development,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised EVERY on the deal while Pillsbury Winthrop Shaw Pittman represented McWin. The EVERY Company, the leading precision fermentation platform accelerating a...
You must be a Standard 1 Year member to access this content.
